Abstract. This study assessed hemodialysis adequacy in pediatric centers. Monthly adequacy data were requested in NAPRTCS enrollees on hemodialysis for at least 6 mo. Data forms were returned for 147 children from 32 centers. Data are presented for the 138 children (57% boys, 45% black) that were dialyzed 3 times/wk, representing 2282 patientmonths of follow-up. Pre-and postdialysis BUN levels were reported in all children. Kt/V values were reported in 76 children; however, sufficient data were obtained to calculate Kt/V in 129 children. On average, 14.9 Kt/V and 15.2 urea reduction ratio (URR) values were calculated per child. Aggregate dialysis dose was defined as adequate if Kt/V was Ͼ1.2 in at least 75% of calculated Kt/V measures within a subject. Mean Ϯ SD age was 11.3 Ϯ 3.7 yr (median, 12.0 yr). Hemodialysis dose was variable within subjects (median CV%: URR 8.2, Kt/V 16.9). Aggregate dialysis dose was adequate in 70% of subjects. Multivariate logistic regression showed male gender (OR, 0.41; 95% CI, 0.16 to 0.98), black race (OR, 0.28; 95% CI, 0.11 to 0.67), larger body surface area (fourth versus first quartile: OR, 0.22; 95% CI, 0.05 to 0.80), and absence of reported Kt/V at the treating center (OR, 0.26; 95% CI, 0.10 to 0.62) were significant predictors of inadequate dialysis dose. Age, renal diagnosis, and center size were not associated with adequacy. Racial and gender disparities in hemodialysis dose existed among children at specialized academic pediatric centers and a substantial proportion received inadequate hemodialysis.
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Numerous studies in adults have demonstrated a strong correlation between hemodialysis dose and clinical outcomes (1-5). In 1997 and 2000, the National Kidney Foundation Dialysis Quality Initiative (NKF-DOQI) Hemodialysis Adequacy Work Group published evidence-based clinical practice guidelines (6, 7) . The guidelines stated the hemodialysis dose should be measured as the fractional clearance of urea as a function of its distribution volume (Kt/V), that dose should be measured at least once per month, and that the minimum delivered Kt/V should be 1.2. In the absence of any data regarding the association between hemodialysis dose and outcomes in pediatric patients, the guidelines stated that the hemodialysis dose for children should be at least that recommended for adults. The opinion of the Work Group was that higher Kt/V values may be easier to achieve in children because of their relatively low volume of distribution of urea, and that a higher Kt/V may facilitate growth (6) . Subsequently, pediatric nephrologists have advocated an upward revision in pediatric dialysis dose guidelines (8 -11) .
Pediatric patients comprise less than 1% of the total hemodialysis patient population in the United States. In 2000, the point prevalence of dialysis patients less than 20 yr of age was 2245 per million, compared with 46,390 per million among adults 20 to 44 yr of age (12) . In addition, most children spend significantly less time on dialysis before transplantation, compared with adults (13) . Finally, the majority of young children are treated with peritoneal dialysis (13) . As a result, even the largest pediatric hemodialysis programs are quite small by adult program standards and rarely exceed 10 to 15 patients per facility. Data on pediatric hemodialysis dosing practices in young children are especially sparse.
In 2002, the Centers for Medicare and Medicaid Services (CMS) reported the results of the cross-sectional 2000 Clinical Performance Measures Project of hemodialysis adequacy among 433 adolescents 12 to 18 yr of age (14) . Black race and male gender were identified as independent predictors of inadequate hemodialysis. Reports of hemodialysis adequacy in younger children are limited to two small case series with three and ten children less than 12 yr of age, respectively (8, 15) .
The CMS study did not address whether an adult nephrologist or a pediatric nephrologist provided dialysis care for these adolescents. Furth et al. (16, 17) have shown that pediatric specialization and experience influence physicians' dialysis treatment choices in children and adolescents. It is not known whether the racial and gender disparities in dialysis dose observed in adolescents in the CMS study are present in younger children and in adolescents treated exclusively at specialized pediatric dialysis centers. The objective of this study was to collect longitudinal data on hemodialysis dose among incident pediatric hemodialysis patients treated at academic pediatric nephrology centers. This population represents the subset of children and adolescents treated by highly specialized physicians and nurses in small dialysis units where barriers to the delivery of adequate hemodialysis should be minimized.
Materials and Methods

Study Population
The North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) is a voluntary research initiative of pediatric nephrologists. The data collected by each center is sent to the Data Coordinating Center (DCC). A dialysis modality initiation form is completed after 30 d of dialysis. Information regarding dialysis status, growth, medications, complications, and hospitalizations is updated every 6 mo after dialysis initiation. Additional information is provided in the event of an access revision, dialysis modality termination, renal transplantation, or death. NAPRTCS did not collect information on dialysis dose before 2003.
Study Sample
Children and adolescents within the NAPRTCS registry who began maintenance hemodialysis between January 1994 and September 2000 and who received at least six consecutive months of hemodialysis were included in the study. The latter criterion was instituted to restrict collection of adequacy data to established dialysis patients, and to provide multiple measures of dose per subject. Owing to the focus on dialysis dosing practices in children with ongoing growth and development, the study was limited to subjects younger than 18 yr of age, at Tanner maturation stages I to IV at the time of dialysis initiation.
Data Collection Form and Data Elements
A hemodialysis adequacy data collection form was developed to supplement the information routinely collected by NAPRTCS. Participating centers were asked to provide monthly measures of the following: paired pre-and postdialysis BUN and weight, height, duration of dialysis, dialyzer manufacturer and characteristics, the number of scheduled treatments per week, and Kt/V. In the event of residual renal function, information regarding timed urine collections, urine volume and urine urea nitrogen was requested. The data collection form requested the "delivered time on dialysis" associated with each urea reduction ratio (URR) and Kt/V measure. The instructions were as follows: "Enter the patient's ACTUAL DELIVERED TIME on dialysis during the session when the pre-and post-dialysis BUN levels were drawn. Do not enter the prescribed time on dialysis. If using finish time minus start time to calculate delivered time, deduct time for any interruptions during dialysis."
During the study interval, many dialysis units used the URR as a measure of adequacy and did not calculate Kt/V. Among the centers reporting Kt/V results, varied formulas were used to calculate Kt/V. Therefore, to provide a measure of Kt/V in patients without a reported value, and to use a uniform Kt/V formula across all patients, the DCC calculated Kt/V in all subjects with sufficient data on the completed form. Kt/V was calculated according to the Kt/V natural logarithm formula (18) . This formula has been validated in children (19) , and is recommended by the NKF-DOQI guidelines as an acceptable alternative to formal urea kinetic modeling. This formula assumes that the patient is dialyzed three times per week; therefore, analyses of dialysis dose are limited to those months in which a child was dialyzed three times weekly. For the analyses presented here, the Kt/V calculated by the treating center and reported on the data collection form is referred to as Kt/V Center , and the Kt/V calculated by the DCC is referred to as Kt/V DCC .
Data Analyses
Two approaches were used to define adequate dialysis in each subject. The first approach was based on the mean Kt/V and URR within a subject. This approach has been used throughout CMS reports in children and adults (14) . The second approach was based on the aggregate dialysis index, defined as the proportion of Kt/V measures within an individual subject that were greater than or equal to the DOQI minimum recommended dose of 1.2. Similarly, the URR aggregate dialysis index was defined as the proportion of URR measures within an individual subject that were greater than or equal to the DOQI minimum of 65%.
Standard univariate and multivariate statistical methods were used for data analysis.
2 tests were performed for comparison of binary and categorical endpoints, and t tests for comparison of continuous variables. Assessment of the relationship between vascular access and dialysis dose in the multivariate models used a 3 level variable for catheter versus fistula versus graft. Multivariate linear and logistic regression analyses were conducted to determine significant associations of patient characteristics with hemodialysis adequacy. Both backward elimination (factors stayed at 0.1 level) and forward selection (factors entered at 0.1 level) methods were used, with a significance level at 0.05. Because of the high event rate (proportion of subjects with inadequate dialysis as defined by the aggregate index), approximate relative risk (RR) estimates were calculated as a transformation of the OR as follows: RR ϭ OR/[(1 Ϫ P 0 ) ϩ (P 0 ϫ OR)], where P 0 ϭ the incidence of inadequate dialysis in the unexposed group (20) .
All of the variables considered for inclusion in the multivariate models were chosen on the basis of published studies of adequacy in adults that demonstrated effects of age, gender, race, body size, dialysis access, and years on dialysis. Primary renal diagnosis was included because the underlying disease may confound relationships, such as age, gender, and body size. For example, focal segmented glomerulosclerosis is more common in blacks and steroid therapy may affect body size. We reported an analysis of the subjects means and confirmed very similar results in mixed model and GEE analyses. Because of the large number of centers relative to the sample size, there is substantial confounding between center and race (e.g., 18 centers have only a single race group).
Results
Patient Enrollment
A total of 312 eligible subjects were identified at 68 NAPRTCS centers. Of these 68 centers, 34 (50%) agreed to complete the hemodialysis adequacy data collection forms. The 34 participating centers represent all regions of the United States and Canada (Appendix). A total of 204 eligible children were identified at these 34 centers. Of these, data collection forms were completed for 147 eligible subjects (72%), providing a total of 2968 patient-months of observation. The median number of children from each center was three (range, 1 to 10).
Patient Characteristics
The patient characteristics are summarized in Table 1 . The predominance of boys in the study population is consistent with the greater incidence of congenital renal disorders in male patients. The significantly decreased standard deviations score (SDS) for height and weight are consistent with prior studies of poor growth in renal disease (21) . Body mass index (BMI) SDS, body surface area (BSA), and duration of dialysis did not differ significantly according to race or gender.
There are two potential sources of selection bias. First, the 34 centers that agreed to participate may be different than the 34 centers that declined participation. Within the NAPRTCS registry, age, gender, race, growth, primary renal diagnosis, and year of dialysis initiation were compared among children dialyzed at the 34 participating and 34 nonparticipating centers. Most factors were equivalently distributed in the participating and nonparticipating centers, with the exception of differential minority representation. Among participating centers, 45% of subjects were black, compared with 31% in nonparticipating centers (P Ͻ 0.001). In addition, participating centers include more recent cases (P Ͻ 0.01). The second source of selection bias is that data collection forms were completed for 72% of eligible subjects at the 34 participating centers. Subject age, gender, race, anthropometrics, primary renal diagnosis, and year of dialysis initiation did not differ for respondents and nonrespondents.
Hemodialysis Frequency
By the end of the first month after dialysis initiation, 7, 131, and 10 patients were dialyzed two, three, and four times weekly, respectively. Of those dialyzed two times per week, four subsequently switched to three times weekly. Among those dialyzed four times weekly, three subsequently reduced dialysis frequency to three times weekly. Dose results are reported for the Kt/V and URR results obtained in the 138 subjects, limited to the months during which dialysis was performed three times weekly. This represented 2282 patientmonths of follow-up.
Frequency of Assessment of Hemodialysis Dose at Participating Centers
The completed hemodialysis adequacy data collection forms included at least one set of paired BUN levels in all subjects. The median proportion of monthly assessments that included paired BUN levels was 92% of months; the proportion varied from 6% to 100% of months. Although 33% of subjects had URR values reported for every month, URR values were measured less frequently than one in 2 mo in 20% of subjects, and less frequently than one in 3 mo in 15% of subjects. In contrast, only 76 (55%) of 138 patients had at least one measure of Kt/V Center .
Sixty subjects (41%) had confirmed negligible urine output. Among the remaining subjects, 10 had information on urine output, but the case report forms for the remaining 77 subjects (52%) did not provide any urine output data. Among the 10 subjects with urine output, data from timed urine specimens were reported in only 19% of the monthly assessment per patient. Therefore, most centers were not measuring residual renal function, and there were insufficient data to include residual renal function in the assessment of dialysis adequacy in the majority of patients. The proportion of subjects with confirmed negligible urine output did not vary according to gender (48% of boys versus 42% of girls, P ϭ 0.5). However, black subjects were significantly more likely to have documented negligible urine output compared with nonblack subjects (62% versus 32%, P Ͻ 0.001).
Available Measures of Hemodialysis Dose
At least one measure of URR was available in all 138 subjects and at least one measure of Kt/V DCC was generated in 129 subjects. A total of 1921 measures of Kt/V DCC and 2097 measures of URR were available in the 138 subjects over 2822 mo of patient follow-up. The mean Ϯ SD number of Kt/V DCC and URR values per patient was 14.9 Ϯ 11.3 and 15.2 Ϯ 11.6, respectively.
Intrapatient Variability
Because of the large numbers of measurements available for each subject, dose variability within subjects was examined. The median coefficient of variation (CV%) for Kt/V DCC was 16.9% (range 2 to 72), and URR was 8.2% (range 0 to 38). The CV% for Kt/V DCC and URR were not correlated with the number of measures of dose or dose levels. An ANOVA to evaluate age, gender, and race effects on the CV% suggested that black patients had marginally greater CV% than nonblack patients (Kt/V: P ϭ 0.069; URR: P ϭ 0.098).
Changes in Dose within Subjects
The duration of dialysis was widely variable, and the relationship between dialysis dose and patient characteristics may be confounded by dialysis duration. Therefore, the relationships between patient characteristics, dialysis duration, and dose were examined. Dialysis duration was not correlated with age, gender, race, or BSA. The mean Kt/V DCC and URR in the first 6 mo of dialysis did not differ between subjects with less than 12 mo follow-up compared with those with more than 12 mo of follow-up. However, among patients with at least 12 mo of follow-up, there was a significant increase in mean Kt/V DCC and URR from the first 6 mo to the second 6 mo (Kt/V DCC : 1.43 Ϯ 0.31 versus 1.55 Ϯ 0.38, P Ͻ 0.01; URR: 68.8 Ϯ 7.6 
Duration of the Treatment Session
Time measurements were provided for 2725 assessments over the 2968 mo of patient follow-up. These measurements suggested a predominance of half-hour increments, e.g., 4 h (36%), 3 h (31%), and 3.5 h (13%), with the next highest (2.5 h) being 3% of the assessments. A mixed model for repeated measurements was used to examine duration of the treatment session as a function of age group, gender, black race, and BSA, as well as SDS for height, weight, and BMI. Only the age and race variables were significant, with black patients having 8 min less dialysis than nonblack subjects (P Ͻ 0.02), and preadolescents (6-to 12-yr-olds) having 21 min less dialysis than older children (P Ͻ 0.001).
Hemodialysis Adequacy Mean Dialysis Dose
Overall, 82% of subjects had a mean Kt/V DCC Ն1.2 and 78% had a mean URR Ն65%. The mean Kt/V Center , Kt/V DCC , and URR were evaluated according to age, gender, race, BMI SDS, BSA quartile, primary renal diagnosis, access, and center volume quartile. Table 2 summarizes the significant factors in the univariate analysis, and Figure 1 illustrates the Kt/V DCC distribution according to gender, race, and age. Girls received significantly higher doses than boys, as measured by Kt/ V Center , Kt/V DCC , and URR. Whites received significantly higher doses than blacks, as measured by Kt/V DCC and URR. Of note, the magnitude of the racial differences in Kt/V Center was less and did not achieve statistical significance. The average values for URR and Kt/V DCC were assessed in the children with no Kt/V Center , compared with the children with at least one Kt/V Center . As summarized in Table 2 , the mean Kt/V DCC and URR were significantly greater in the children with at least one Kt/V Center , compared with those with no Kt/V Center .
Among the 34 centers contributing data, 17 centers provided at least one measure of Kt/V Center . In 16 of these centers, every patient had at least one Kt/V Center . Larger center volume was associated with significantly greater likelihood of measuring Kt/V. Among the 10 patients in the smallest quartile for center volume, Kt/V Center was provided in 2; among the 50 children in the largest quartile for center volume, Kt/V Center was provided in 36 (P Ͻ 0.01). The mean Kt/V Center , Kt/V DCC , and URR were compared according to era: 1994 to 1997 versus 1998 to 2001. No significant differences were detected. The availability of Kt/ V Center measures was compared according to era. A significantly greater proportion of the dialysis treatments in the later era included measures of Kt/V Center , compared with dialysis treatments in the earlier era; 47.4 versus 37.2% of months, P Ͻ 0.001. Similarly, patients initiating dialysis in the later era were more likely to have Kt/V Center results than patients initiating dialysis in the earlier era (P Ͻ 0.05).
To determine whether differences in vascular access confounded the relationships between gender, race, and dialysis adequacy, vascular access was compared according to gender and race at 6 and 12 mo after dialysis initiation. At 6 mo, 58% of boys, 58% of girls, 60% of whites, and 54% of blacks were dialyzed with a catheter. At 12 mo, the proportions were 53% of boys, 50% of girls, 54% of whites, and 48% of blacks. None of these differences was statistically significant (all P Ͼ 0.42). In addition, the frequency of dialysis access revisions was comparable among subjects receiving adequate dialysis (1.17 revisions per year) compared with subjects receiving inadequate dialysis (0.89 revisions per year)
Multivariate regression models were constructed for Kt/ V DCC and URR, adjusted for the covariates considered in the univariate analyses. Backward elimination and forward selection methods resulted in identical final models for each of the dose outcomes. The models are summarized in Table 3 . Both models showed that male gender, greater BSA, black race, and lack of any Kt/V Center measures were significant and independent predictors of less hemodialysis dose. 
Aggregate Dialysis Index
Aggregate dialysis index was defined according to the proportion of measures within an individual that were greater than or equal to the recommended minimal Kt/V of 1.2. Figure 2 summarizes the aggregate dialysis index according to age, gender, and race. For example, 60% of white subjects achieved the minimum DOQI recommended dose in at least 90% of their Kt/V DCC measures. In contrast, only 33% of black subjects received the minimum DOQI recommended dose in at least 90% of their Kt/V DCC measures.
Adequate aggregate dialysis index, defined as greater than 75% of doses within an individual subject exceeding the minimum DOQI recommendation (for URR or Kt/V), was achieved in 70% of subjects with Kt/V DCC and 62% of subjects with URR. The proportions of subjects with adequate aggregate dialysis were compared in univariate analyses according to gender, age, race, BMI SDS, BSA quartile, primary renal diagnosis, access, center volume quartile, and availability of Kt/V Center . Only race was significantly associated with an adequate aggregate dialysis index for Kt/V DCC and URR (both P Ͻ 0.02).
Multivariate logistic regression models were constructed for Kt/V DCC and for URR to identify predictors for inadequate dialysis. Backward elimination and forward selection methods resulted in identical final models for each of the dose outcomes. The models are summarized in Table 4 . Both the Kt/V DCC and URR models showed that black race, lack of Kt/V Center , and larger BSA were independently associated with inadequate dialysis. Male gender was marginally associated with inadequate dialysis. Table 4 presents the odds ratios for the various effects. The approximate relative risks for the effect of nonblack race are 1.27 and 1.43 for adequate Kt/V DCC and URR, respectively, after adjusting the odds ratios by the overall respective prevalence rates for adequate dialysis (20) . Figure 3 demonstrates the relationship between the two measures of dialysis adequacy, mean Kt/V DCC , and the aggregate Kt/V DCC dialysis index. The horizontal and vertical lines represent the cutoffs for the definitions of adequate dialysis for the mean Kt/V DCC and the aggregate Kt/V DCC dialysis index, respectively. Subjects in the right upper quadrant would be classified as receiving adequate dialysis according to both measures, and subjects in the left lower quadrant would be classified as receiving inadequate dialysis according to both measures. The left upper quadrant represents the 15 subjects (12%) in whom the mean Kt/V DCC was at least 1.2 but less than 75% of treatments reached this threshold.
Discussion
This assessment of 148 incident hemodialysis patients is the largest study of hemodialysis adequacy published to date in young children, permitting evaluation across broad ranges of age and body size. These data demonstrated that 88% of white children and 73% of black children received a mean Kt/V Ն1.2. A concurrent adult study reported that 87% of whites and 84% of blacks had a mean Kt/V Ն1.2 (22) . Similarly, the mean Kt/V DCC values in white and black children within our NAPRTCS study were 1.62 Ϯ 0.40 and 1.40 Ϯ 0.37, respectively. Within a national random sample of adults, the mean Kt/V values in white and black adults were 1.50 Ϯ 0.29 and 1.46 Ϯ 0.28, respectively. Overall, the mean delivered Kt/V in white children was slightly higher than in white adults; however, the racial disparity in children was greater than in adults. These data do not support the notion that children treated by pediatric nephrologists receive significantly greater dialysis doses than adults. Furthermore, these data raise important concerns regarding barriers to adequate dialysis among black children.
The racial and gender disparities are consistent with the prior CMS study in adolescents (14) . Our data demonstrate that this disparity also exists within younger children and in children treated at academic pediatric centers. Racial and gender disparities have been observed in adults since the inception of the end-stage renal disease (ESRD) Core Indicators Project (23, 24) . Previous studies have shown that a greater percentage of blacks and male patients receive a dialysis dose below the recommended KDOQI minimum (23-25).
A possible explanation for these disparities is the relatively greater lean body mass and urea distribution volume for body weight in male subjects and blacks (23, 26) . The decreased dose in blacks has also been attributed to racial differences in vascular access and shorter treatment time (24, 25) . Palevsky et al. (25) recently conducted a study to identify remediable barriers to the delivery of adequate dialysis in adults. The study confirmed that black race and male gender were associated with lower delivered dose. Characteristics of inadequate dialysis included shorter treatment duration, patient weight greater than 100 kg, delivered blood flow rate less than prescribed, and the use of catheters for dialysis access. A study of compliance in hemodialysis patients reported that blacks were twice as likely to skip or shorten a dialysis treatment, compared with whites (27) . Of note, if blacks were more likely to miss treatments, the lower Kt/V documented in these subjects would underestimate the degree of dialysis inadequacy. In addition, we believe that centers would be less likely to perform the Kt/V measure on a day that a patient arrived late or left early. Again, the measurement of Kt/V on a day that the patient came to dialysis and completed the prescribed treatment may serve to underestimate the degree of dialysis inadequacy, raising further our concerns regarding dialysis adequacy in at-risk subjects.
The multivariate analyses presented here included measures of body size (BSA), adiposity (BMI SDS (28)), vascular access, gender, age, race, renal diagnosis, and center volume. Despite adjustment for body size and vascular access, black race and male gender remained significant predictors of inadequate dialysis. A prior cross-sectional study demonstrated that patients who recently initiated hemodialysis therapy received less dialysis than patients with longer histories of dialysis therapy (29) . This was confirmed here; however, months of dialysis treatment did not differ according to race and gender, and did not contribute to the observed disparities. We did not collect data on blood flow rate; however, the lack of gender or racial differences in vascular access at 6 or 12 mo does not support that hypothesis that differences in effective blood flow explained the gender and racial disparities. Finally, the duration of the dialysis session may contribute to the racial disparity. We detected a small (8 min) but significant difference in dialysis duration according to race. We are concerned that our data on the length of the dialysis session was subject to rounding error, which may be greater among subjects electing to shorten their dialysis treatment; therefore, our measures of treatment time may not fully capture differences across subjects.
Importantly, these data uncovered a potential source of systematic deficiency in the delivery of hemodialysis in children: the lack of any measures of Kt/V by the treating center was associated with significantly less dialysis dose. The magnitude of this effect was great; the odds of receiving adequate dialysis in a child with no Kt/V Center results was fourfold less compared with a child with at least one Kt/V Center , adjusting for patient characteristics.
A significant strength of this study is the availability of multiple measures of dialysis dose per subjects. To our knowledge, this is the first study to assess an incident cohort, to assess changes in dialysis dose over time, and to assess withinsubject variability in dose. Most studies of dialysis adequacy, including the CMS studies, were limited to a 3-mo interval, and patients were classified as adequate on the basis of one to three measures of Kt/V. Given the sizable variability in dose measures, this provides an imprecise estimate. Furthermore, use of the traditional definition of adequacy (mean dose greater than or equal to the minimum DOQI recommendations) may result in a patient classified as adequate when a substantial proportion of the measures are below the DOQI recommended minimum. This is demonstrated in our data, in which 12% of subjects with a mean Kt/V Ն1.2 received a Kt/V of less than 1.2 in at least 25% of treatments. Future studies are needed to determine whether the aggregate dialysis index is better correlated with clinical outcomes than the mean Kt/V. This study is limited by several constraints. First, 34 of 68 eligible centers agreed to participate. Among participating centers, eligible patients received hemodialysis more recently; this likely reflects greater availability of more recent dialysis medical records, and the results reflect more recent practice. The data provided by the 34 participating centers encompassed 72% of their eligible subjects. The patient characteristics in the enrolled subjects did not differ from the children who were not enrolled. Although we cannot rule out selection bias, we doubt that the subjects for whom data were not provided received greater dialysis doses. Therefore, selection bias, if present, likely resulted in an underestimate of inadequacy of delivered dialysis dose in children. Furthermore, the participating centers included most of the country's larger academic pediatric ESRD programs and provided broad geographic representation throughout the United States and Canada. Second, information was not collected on blood flow rates. Therefore, it was not possible to determine whether poor blood flow or short treatments contributed to the lower dose observed in male subjects and blacks. Third, in this retrospective study, information was not available regarding the method used to obtain the postdialysis BUN samples, and this was not standardized across dialysis centers. Although the timing of this sample can influence the BUN concentration obtained, it is unlikely that differences in the sampling technique influenced the BUN concentration in a systematic manner across gender and race. Fourth, body weight, height, BMI, and BSA may not capture difference in lean muscle mass.
Last, data on residual renal function were incomplete. However, we doubt that centers were delivering a lower dose in subgroups, such as male patients or black patients, under the assumption that the (unmeasured) residual renal function contributed to clearance. The fact that black patients are significantly more likely to have documented negligible urine output raises even greater concerns about dialysis adequacy in this population. Furthermore, among subjects with confirmed negligible urine output, 67% received adequate dialysis dose (as defined by the aggregate index); among subjects with no documentation of urine output, 72% received adequate dialysis. Therefore, these data do not support the hypothesis that the lower dialysis dose in blacks was the result of greater residual renal function, or the possibility that dialysis dose differed according to urine output. Although these limitations prevent identification of the cause of the inadequate dialysis in male patients and blacks, these limitations do not obviate the substantial disparities observed in delivered dose. Despite the fact that these children and adolescents were treated in small dialysis units, with specialized physicians and one-on-one care by specialized nurses, barriers to adequate dialysis persisted. Whether the smaller delivered dose in blacks was due to shorter treatments, greater muscle mass, or poor blood flow rates, interventions were needed to overcome these barriers and improve dialysis adequacy. Furthermore, significant opportunities existed to improve the monitoring of hemodialysis adequacy in children-in particular, the monthly monitoring of Kt/V. Although the frequency of Kt/V monitoring improved over the study duration, significant center effects persisted. Fifty percent of centers monitored URR, with no measures of Kt/V.
CMS quality improvement efforts to improve dialysis adequacy include monitoring of patient outcomes, feedback of performance data, and education of clinicians at dialysis centers. These efforts have resulted in a twofold increase in the proportion of patients with an adequate hemodialysis dose, and a significant decrease in the gap between white and black patients from 10% to 3% (30, 31) . Further work is needed to identify barriers to adequate dialysis in children, and to develop quality improvement methods for children on hemodialysis.
